What rights and safeguards protect clinical trial participants?
Clinical trial participants are protected by strict ethical and regulatory safeguards before and throughout a study. Learn how informed consent, ongoing safety monitoring and the right to withdraw help protect participants’ rights.
Personalised Cancer Vaccine Shows Promise in Preventing Melanoma Returning
A personalised cancer vaccine has shown promising results in a Phase 3 clinical trial, helping to prevent melanoma from returning in patients at high risk of their cancer coming back.
British Research Panel Members Contribute to Progressing Type 1 Diabetes Research
Over 1,800 British Research Panel members signed up to the T1DRA study, a type 1 diabetes study led by the University of Bristol. The study aims to find how many adults in the UK are at increased risk of developing type 1 diabetes.
Why Might You Not Be Eligible for a Clinical Trial
Clinical studies often seek participants with specific conditions, treatment histories and health characteristics. Learn why you may not be able to take part, even when the study concerns your condition.
Phase 3 Results for Hepatitis B Treatment Show Functional Cure for 1 in 5 People
An experimental treatment for chronic hepatitis B has shown encouraging results in two large phase 3 clinical trials. The studies involved more than 1,800 adults across 29 countries with around one in five participants achieving a functional cure.
More Women in their 20s are Getting Type 2 Diabetes
A new analysis of NHS data has found a concerning rise in type 2 diabetes among young adults in England. 12,000 people under 30 are now living with type 2 diabetes.
What is the MHRA and why does it matter for patients?
Learn how the Medicines and Healthcare products Regulatory Agency, (MHRA) evaluates medicines, monitors safety, and oversees clinical research in the UK.
UK Begins Trials of Ebola Vaccine
New Ebola vaccine has entered its first human clinical trial. Researchers hope the study will demonstrate the vaccine is safe and capable of generating an immune response.
Multiple Sclerosis: What if stopping treatment could be beneficial for patients?
Discover how the TWINS study for Multiple Sclerosis, decoded by Prof. Collongues, explores treatment discontinuation to improve the quality of life and safety of stable patients.
Listening to All Voices: What Patient Advocate Carole Scrafton Wants Researchers to Know
Patient advocate Carole has been motivated to support research from a young age. She reminds us that research is strongest when more voices are actively included throughout the process.